SynVivo is an established, commercial-stage company with initial sales & a seasoned management team that is seeking capital to formalize the sales, marketing and distribution of this new technology. Beyond its current sales focus, we intend to introduce our innovative technology to the personalized medicine space, starting with cancer. With major cancer centers engaged, the company will have true world-class support for the technology.